Grant Gallagher;Nicholas Megjugorac;Shekar Srinivas;Jihong Dai;Joyce Eskdale;Grant E. Gallagher
发明人:
Grant Gallagher,Joyce Eskdale,Shekar Srinivas,Jihong Dai,Nicholas Megjugorac,Grant E. Gallagher
申请号：
US12290052
公开号：
US20120058081A1
申请日:
2008.10.27
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides a method of treating Th2-associated diseases and disorders by modulating the expression or secretion of IL-4, IL-5 and IL-13 using interferon lambda (IFN-λ). For Th2-associated diseases and disorders, cells of a patient having a Th2-associated disease or disorder are treated ex vivo, with IFN-λ and returned to the patient. The present invention also provides a method of ex vivo treatment, in conjunction with co-administration of IFN-λ
